Literature DB >> 35997464

An Exploration of Rural-Urban Residence on Self-Reported Health Status with UK Cancer Survivors Following Treatment: A Brief Report.

David Nelson1,2, Ian McGonagle3, Christine Jackson3, Ros Kane3.   

Abstract

OBJECTIVE: To explore the effect of rural-urban residence on the self-reported health status of UK cancer survivors following primary treatment.
DESIGN: A post-positivist approach utilizing a cross-sectional survey that collected data on demographics, postcode and self-reported health status.
METHODS: An independent samples t test was used to detect differences in health status between rural and urban respondents. Pearson's χ2 was used to control for confounding variables and a multivariate analysis was conducted using Stepwise linear regression.
SETTING: East Midlands of England. PARTICIPANTS: Adult cancer survivors who had undergone primary treatment in the last five years. Participants were excluded if they had recurrence or metastatic spread, started active oncology treatment in the last twelve months, and/or were in receipt of palliative or end-of-life care. MAIN OUTCOME: Residence was measured using the UK Office for National Statistics (ONS) RUC2011 Rural-Urban Classifications and Health Status via the UK ONS self-reported health status measure. ETHICS: The study was reviewed and approved (Ref: 17/WS/0054) by an NHS Research Ethics Committee and the Health Research Authority (HRA) prior to recruitment and data collection taking place.
RESULTS: 227 respondents returned a questionnaire (response rate 27%). Forty-five percent (n = 103) were resident in a rural area and fifty-three percent (n = 120) in an urban area. Rural (4.11 ± 0.85) respondents had significantly (p < 0.001) higher self-reported health statuses compared to urban (3.65 ± 0.93) respondents (MD 0.47; 95% CI 0.23, 0.70).
CONCLUSION: It is hoped that the results will stimulate further work in this area and that researchers will be encouraged to collect data on rural-urban residency where appropriate.

Entities:  

Keywords:  United Kingdom; cancer survivors; health status; rural health; urban health

Year:  2022        PMID: 35997464      PMCID: PMC9397029          DOI: 10.3390/nursrep12030056

Source DB:  PubMed          Journal:  Nurs Rep        ISSN: 2039-439X


1. Introduction

Cancer is a leading cause of death globally and accounted for nearly ten million deaths in 2020 [1]. The burden of cancer continues to grow, exerting considerable physical, emotional and financial pressure on people living with and affected by cancer, as well as on health and social care systems around the world [2]. The Global Burden of Disease (GBD) study has identified large heterogeneities with regard to cancer care and survival which can be attributed to exposures to risk factors, lifestyles, access to treatment and screening, as well as different economic and geographic settings [3]. The majority of the cancer survivorship literature with a focus on geography and specifically with regard to rurality tends to be from Australia and North America [4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]. Whilst these geographies are significantly larger than the UK and what constitutes ‘rural’ in the UK might be very different than in North America or Australia, it has been well documented that cancer survivors in rural settings experience a number of additional challenges compared to their urban counterparts [13,16,19,20,21,22,23]. Examples include having to travel long distances for treatment, less access to bespoke support and emotional and physical isolation. Additionally, research has highlighted the benefits of rural living and ‘green spaces’ in improving physical and mental health and there are a number of benefits of rural living for cancer survivors [24,25]. For example, rural communities frequently value close relationships with family and friends, community members and religious institutions [26,27], which constitute significant sources of social support [24] vital to coping with or minimizing emotional distress when experiencing a traumatic life event, such as a cancer diagnosis. Butow et al. [21] maintain that this could be a potential reason for differences and that rural populations might be less inclined to ask for help; interestingly, recent research in Australia highlighted that people affected by cancer in rural areas were less likely to report higher levels of distress compared to those from urban areas [6]. Our recent research has looked specifically at the role of rural–urban residency on the self-management and cancer-related self-efficacy of UK cancer survivors [28,29]. In the UK, almost a fifth (10.82 million) of the total population (56.39 million) reside in rural areas [30]. It is therefore important to understand the experiences and health outcomes of cancer survivors who reside in both rural and urban areas. However, we still do not understand the impact of geography on health status as it directly relates to UK populations who have completed primary treatment for cancer. This research aimed to address that gap by exploring the impact of rural–urban residence on self-reported health status of cancer survivors who were post-treatment in the East Midlands region of England.

2. Methods

2.1. Study Design

The study utilized a post-positivist approach via a cross-sectional self-completion postal survey that was administered to adult cancer survivors who had completed primary treatment. The Strengthening the Reporting of Observational studies in Epidemiology (STROBE) Checklist for cross-sectional studies was adhered to when reporting this study [31]. The research was approved by a School of Health and Social Care Ethics Committee (Ref: 12/02/17) as well as by a National Health Service (NHS) Research Ethics Committee (REC) and the Health Research Authority (HRA) (Ref: 17/WS/0054; IRAS Project ID: 204679). NHS approvals had to be in place, given the use of NHS systems and staff to support the recruitment of eligible participants. Furthermore, confirmation of capacity and capability to deliver the study was authorized by both participating NHS trusts’ Research and Development (R&D) departments.

2.2. Setting

The study setting was the East Midlands of England which has been considered a microcosm of the UK in terms of demographics, urban-rural dynamics and deprivation [32].

2.3. Questionnaire Design

The questionnaire was developed by the research team using the extant literature and overseen by a project Steering Group that had representation from clinical oncology professionals, senior staff from a UK cancer support charity and health professionals from the local NHS Clinical Commissioning Group (CCG), as well as an individual with lived cancer experience. The questionnaire was piloted with a patient and public involvement (PPI) group prior to finalising the content. It collected data on demographics, self-reported health status and postcode to ascertain rural–urban residence. Clinical data on cancer type was provided anonymously by the participating NHS trusts.

2.3.1. Demographics

The survey collected data on a range of demographics: age, gender, living arrangement, marital status, employment status, qualifications and income.

2.3.2. Health Status

For health status, we used the UK Office for National Statistics (ONS) measure in which participants were asked the question ‘How is your health in general?’ and they could rate their health as ‘Very Good’, ‘Good’, ‘Fair’, ‘Poor’ or ‘Very Poor’. This method has been used in the UK census [33] and was in line with existing research exploring rural–urban differences in health behaviours and health status with American cancer survivors that were also asked to self-report their health status [8,9].

2.3.3. Rural–Urban Residence

Respondents were asked for their postcode and rural–urban residence was defined based on the UK ONS RUC2011 Rural Urban Classifications [34] using the ONS postcode directory lookup tool (https://onsdigital.github.io/postcode-lookup/ last accessed on 1 May 2022) which has been recommended for statistical analyses by the UK Department for Environment, Food and Rural Affairs (Defra) [35]. Participants can be assigned to one of four urban categories or six rural categories. To allow for comparison between the two groups, respondents were assigned to a dichotomous variable that categorized them as rural or urban. This approach of using official statistics to define rural–urban residence has been adopted internationally in other cancer research studies in high income settings [8,9,13]. The ONS measure for Index of Multiple Deprivation (IMD) was also assigned utilizing postcode data [36].

2.4. Participant Eligibility

Participants were included if they were aged 18 years and over, had a confirmed cancer diagnosis and had undergone treatment in the last five years, and excluded if they had evidence of recurrence or metastatic spread, started active oncology treatment in the last twelve months and/or were currently being treated for palliative or end-of-life care.

2.5. Sample Size Calculation

The first author (DN) worked with an experienced statistician to calculate the sample size and a letter of support was provided to the ethics committee outlining how the sample size was calculated. The calculation was performed for an independent samples (rural and urban) t test in relation to the outcome measure. The final calculation allowed for a 20 percent difference between scores, assumed a statistical significance level of 0.05 and a test with 95 percent power giving a required sample of 417. In line with similar cancer survivorship research in the West Midlands of England that also used a self-completion postal questionnaire [37,38], the sample size was doubled as it was anticipated that 50 percent of participants would respond. Therefore, 834 participants that met the above eligibility criteria were identified and sent a questionnaire.

2.6. Recruitment

Access to the sample population was sought via cancer centre staff at two acute NHS Trusts who acted as gatekeepers to the study population. These were both based in the East Midlands of England, one which covers a sparse and rural county and another with a high proportion of urban dwellers. The managers of both cancer centers as well as their lead cancer nurse specialists (CNSs) were briefed on the eligibility criteria and confirmed that they could identify and recruit potential participants via their patient database on behalf of the research team. An information analyst at each trust led the identification of potential participants using their patient database. The research team did not have access to identifiable patient information. A random sample of 834 eligible participants (417 at each NHS site) were identified and sent a printed research pack in the post that included an NHS-branded invitation from the lead CNS at each site, a participant information sheet, questionnaire and a freepost return envelope to the lead researcher’s work address. These materials were designed to tell the participant more about why they were invited, the purpose of the research and the conditions of taking part. The draft study materials were piloted with five volunteers who had lived experience of cancer prior to seeking ethical approval. The research packs were sent out in June 2017 at one site and in September 2017 at the other participating NHS site.

2.7. Consent

It was made clear on the information sheet and questionnaire that by completing and returning the questionnaire, the participant was giving their consent to take part and the conditions were outlined in the information sheet. Participants could self-select to take part after reading the materials and it was made clear that participation was entirely voluntary. We did not have access to the characteristics of non-responders as recruitment was conducted via the participating NHS trusts on our behalf.

2.8. Analysis

Descriptive statistics were used to characterize the data and an independent samples t test was first used to assess for significance between rural and urban respondents. Pearson’s χ2 was used to assess for confounding variables. Finally, a multivariate analysis was conducted using a stepwise linear regression whilst controlling for confounding variables. We used the forward selection method, which involves using several models testing the addition of each independent variable on the dependent variable (health status) and repeating the process until there is no improvement with statistical significance. With this method, non-significant predictors are excluded from the models. The results were considered significant if p < 0.05. The data were analysed in SPSS software (Ver. 25).

3. Results

A total of 227 respondents (response rate of 27%) returned a questionnaire, and the mean overall age was 66.86 years ±11.22 (range 26–90). Fifty-two percent (n = 119) were female and forty-eight percent (n = 108) were male. Forty-five percent (n = 103) were resident in a rural area and fifty-three percent (n = 120) in an urban area. When comparing between urban and rural participants in our sample, there are some important differences to highlight. More urban participants reported living alone (25% vs. 9%) and being single when compared to rural partipants (32% vs. 13%). Furthermore, twenty-five percent (n = 30) of urban respondents reported having no qualification compared to eight percent (n = 8) of rural respondents. In terms of health status, eighty percent (n = 82) of rural respondents reported their health as very good or good compared to sixty-one percent (n = 73) of urban respondents. Ten percent (n = 12) of urban participants self-reported their health as poor or very poor compared to 4 percent (n = 4) of rural participants. Finally, it should also be noted that less rural respondents self-reported their health as fair compared to urban respondents. Full rural and urban participant characteristics are reported on in Table 1.
Table 1

Rural–Urban Comparison of Participants.

Characteristic Rural Total n = 103UrbanTotal n = 120
n (%)n (%)
Age25–443 (2.9)4 (3.3)
45–5412 (11.7)15 (12.5)
55–6424 (23.3)26 (21.7)
65–7442 (40.8)48 (40.0)
Over 7522 (21.4)27 (22.5)
GenderFemale62 (60.2)57 (47.5)
Male41 (39.8)63 (52.5)
Living arrangementsPartner/Spouse/Family/Friends/Nursing home92 (89.3)90 (75.0)
Alone9 (8.7)30 (25.0)
Marital statusMarried or living with partner89 (86.4)82 (68.3)
Single/Divorced/Separated/Widowed13 (12.7)38 (31.7)
Employment statusEmployed21 (20.4)30 (25.0)
Not Employed3 (2.9)9 (7.5)
Retired69 (67.0)75 (62.5)
Other9 (8.7)6 (5.0)
Qualifications **Professional30 (29.1)30 (25.0)
Qualification19 (18.4)20 (16.7)
Degree or Higher Degree24 (23.3)26 (21.7)
A level or equivalentGCSE/O Levels or equivalent35 (34.0)43 (35.8)
No qualifications8 (7.8)30 (25.0)
Annual household income£0–14,99923 (22.3)31 (25.8)
£15–24,99919 (18.4)36 (30.0)
£25–49,99936 (35.0)35 (29.2)
Over £50,00012 (11.7)8 (6.6)
Primary Cancer TypeBreast39 (37.9)34 (28.6)
Urological22 (21.4)30 (25.2)
Skin8 (7.8)10 (8.4)
Head and Neck7 (6.8)6 (5.0)
Gynecological6 (5.8)4 (3.4)
Lower Gastrointestinal13 (12.6)16 (13.4)
Hematological4 (3.9)6 (5.0)
Upper Gastrointestinal3 (2.9)8 (6.7)
Other1 (1.0)5 (4.2)
Health StatusVery Good or Good82 (79.6)73 (60.9)
Fair17 (16.5)35 (29.1)
Poor or Very Poor4 (3.9)12 (10.0)

Note: Column percentages are reported. Percentages may not total 100% due to missing values. ** Percentages add to more than 100% because participants could select more than one option.

Firstly, the independent samples t test revealed that rural (4.11 ± 0.85) respondents had significantly (p < 0.001) higher self-reported health status compared to urban (3.65 ± 0.93) respondents (MD 0.47; 95% CI 0.23, 0.70). Pearson’s X test revealed that living arrangement (9.768, p = 0.002 *), marital status (11.155, p = 0.001 *) and qualifications (11.886, p = 0.003 *) were all significantly associated with rural–urban residence and so, were entered into our stepwise linear regression model with rural–urban residence and deprivation to adjust for their effect (Table 2).
Table 2

Multiple Predictors of Health Status Using Stepwise Linear Regression.

Health Status
Model 1BSE Bβ t p
Constant3.701 (3.541, 3.860)0.081 45.7520.000
Rural–Urban0.430(0.195, 0.666)0.1190.2393.6030.000
Adjusted R20.053
Model 2
Constant3.427(3.179, 3.675)0.126 27.2540.000
Rural–Urban0.356(0.119, 0.594)0.1210.1982.9580.009
Marital Status0.400(0.119, 0.681)0.1420.1882.8100.013
Adjusted R20.082
Model 3
Constant3.125(2.766, 3.474)0.177 17.6710.000
Rural–Urban0.318(0.081, 0.555)0.1200.1772.6430.009
Marital Status0.357(0.077, 0.637)0.1420.1682.5150.013
Deprivation0.057(0.010, 0.103)0.0240.1592.4050.017
Adjusted R20.103
Model 4
Constant3.271(2.900, 3.643)0.189 17.3490.000
Rural–Urban0.329(0.094, 0.564)0.1190.1832.7550.006
Marital Status0.806(0.304, 1.308)0.2550.3793.1660.002
Deprivation0.055(0.009, 0.101)0.0230.1552.3690.019
Living Arrangement−0.593(−1.145, −0.041)0.280−0.252−2.1160.035
Adjusted R20.117

Notes: Figures in brackets refer to 95% confidence intervals. Outcome Health Status: Very Poor = 1, Poor = 2, Fair = 3, Good = 4, Very Good = 5; Residence: Urban = 0 and Rural = 1; Marital Status: Widowed/Single/Divorced/Separated = 0 Married/Civil Partnership = 1; Deprivation: 1 = Most Deprived through to 10 = Least Deprived. Living Arrangement: 0 = Live alone and 1 = Partner/Spouse/Family/Friends.

Turning to the multivariate analysis in Table 2, the first model showed that rural–urban residence was a highly significant (p = 0.000) predictor of health status. In models two, three, and four, with the inclusion of additional significant predictors, rural–urban residence remained a significant predictor of self-reported health status. Qualifications were not a significant predictor and as such, were excluded from the models. Model 4, which included marital status, living arrangements and deprivation as covariates, was the best fit, although the adjusted r2 (0.117) was only slightly larger than model 3 (0.103). Deprivation, living arrangement and marital status were also significant predictors in this model when controlling for confounding variables. Rural–urban residency still appeared to have a strong effect on health status, but it was marital status which was the most highly significant predictor in model 4. Whilst the adjusted r2 for model 4 could be considered low there was a notable increase from model 1 and 2, suggesting that this model was the best fit, although further research that considers additional covariates is required.

4. Discussion

The research highlighted that in this sample, rural respondents had significantly higher self-reported health statuses compared to their urban counterparts. To the best of our knowledge, this is the first study of its kind that has compared the self-reported health statuses of rural and urban post-treatment cancer survivors in the UK. The findings were at odds with American research where rural participants were more likely to self-report fair and poor health [8,9]. However, their sample was considerably larger and those from rural areas had lower levels of education and health insurance compared to their urban counterparts [9]. Model 4, which included rural–urban residence, marital status, living arrangements and deprivation, was the best predictor of self-reported health status. Marital status was also a highly significant predictor of health status, indicating the importance of social support on health and wellbeing following cancer treatment. That being said, these results from the multivariate analysis should be interpreted with a certain level of caution given the low adjusted r2. However, it is hoped that the results will stimulate further work in this area and that researchers will be encouraged to collect data on rural–urban residency when appropriate. This can be facilitated by asking participants for their postcode and cross-referencing with official statistics, as was the case in this study. This means that the amount of personal data that is required is minimal. The literature maintains that cancer survivors in rural areas tend to be more stoic with regards to their health [39] and are less likely to report high levels of distress [6] compared to their urban counterparts, which could account for some of the differences in health status in this study. Research by McNulty and Nail [10] found that rural participants advocate for themselves, their diagnosis, their survivorship and improved health care, and also have higher levels of trust within their local communities [6] which could subsequently impact positively on health status. Our other research with UK cancer survivors also suggests that people from rural areas have greater confidence to self-manage when compared to their urban counterparts [28]. Further qualitative work is warranted with diverse samples from a range of rural and urban areas to understand why health status and recovery might differ between rural and urban populations who have completed treatment for cancer.

Limitations

A limitation of our study was that we did not have access to the details of non-responders and so could not make any conclusions about those who decided not to take part and whether they came from a rural or urban area. A further limitation was that the required sample size of 417 was not reached; however, the sample of 227 still offered a good split in terms of rural and urban respondents to facilitate a comparative analysis, although not knowing the details of non-responders meant that we could not adjust our analyses to account for non-response We chose to dichotomize rural–urban residency to fit with our approach to analysis, which meant that we might not have been able to distinguish between some of the potential differences between the four urban and six rural categories as designated by the UK ONS. Finally, the use of self-report measures also raises concerns around response bias, which needs to be considered when interpreting the findings.

5. Conclusions

This is the first analysis of self-reported health status between rural and urban cancer survivors in the UK who have completed primary treatment. Much of the existing evidence comes from North America and Australia and this brief report offers a welcome addition to the extant literature within a UK context in which there is a notable gap in the evidence. In this study rural respondents had significantly greater self-reported health status when compared to their urban counterparts which could suggest that there are positives to rural living that can support people with their recovery and longer-term survivorship. That said, we know that rural cancer survivors have unique psycho-social needs that often go unmet and face a number of additional barriers when it comes to receiving optimal care compared to their urban counterparts. Despite our somewhat positive findings in relation to rural respondents self-reporting better health statuses, it is critical that rural oncology providers do not rely on cancer survivors to co-ordinate their own care and that rural cancer nurses work collaboratively with survivors and other cancer support professionals at all stages of the pathway to facilitate a positive patient experience that will support their recovery.
  31 in total

Review 1.  Rural-urban residence and cancer survival in high-income countries: A systematic review.

Authors:  Nina Afshar; Dallas R English; Roger L Milne
Journal:  Cancer       Date:  2019-04-01       Impact factor: 6.860

2.  Multi-Level Assessment to Reach Out to Rural Breast Cancer Survivors.

Authors:  Silvia Gisiger-Camata; Natasia Adams; Timiya ShaRel Nolan; Karen Meneses
Journal:  Womens Health (Lond)       Date:  2016-11-18

3.  Psychosocial needs of rural survivors of cancer and their partners.

Authors:  Michael Glasser; Kimberly Nielsen; Sky Niesen Smith; Candi Gray
Journal:  J Psychosoc Oncol       Date:  2013

Review 4.  What are the unmet supportive care needs of people with cancer? A systematic review.

Authors:  James D Harrison; Jane M Young; Melanie A Price; Phyllis N Butow; Michael J Solomon
Journal:  Support Care Cancer       Date:  2009-03-25       Impact factor: 3.603

5.  Does rurality affect quality of life following treatment for breast cancer?

Authors:  Stephanie A Reid-Arndt; Cathy R Cox
Journal:  J Rural Health       Date:  2010       Impact factor: 4.333

6.  Disparities in mental health between rural and nonrural cancer survivors: a preliminary study.

Authors:  Jessica L Burris; Michael Andrykowski
Journal:  Psychooncology       Date:  2010-06       Impact factor: 3.894

7.  Feasibility of Synchronous Online Focus Groups of Rural Breast Cancer Survivors on Web-Based Distress Self-Management.

Authors:  Robin M Lally; Christine Eisenhauer; Sydney Buckland; Kevin Kupzyk
Journal:  Oncol Nurs Forum       Date:  2018-11-01       Impact factor: 2.172

Review 8.  What is known about the role of rural-urban residency in relation to self-management in people affected by cancer who have completed primary treatment? A scoping review.

Authors:  David Nelson; Ian McGonagle; Christine Jackson; Ros Kane
Journal:  Support Care Cancer       Date:  2020-08-03       Impact factor: 3.603

9.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Degu Abate; Naghmeh Abbasi; Hedayat Abbastabar; Foad Abd-Allah; Omar Abdel-Rahman; Ahmed Abdelalim; Amir Abdoli; Ibrahim Abdollahpour; Abdishakur S M Abdulle; Nebiyu Dereje Abebe; Haftom Niguse Abraha; Laith Jamal Abu-Raddad; Ahmed Abualhasan; Isaac Akinkunmi Adedeji; Shailesh M Advani; Mohsen Afarideh; Mahdi Afshari; Mohammad Aghaali; Dominic Agius; Sutapa Agrawal; Ayat Ahmadi; Elham Ahmadian; Ehsan Ahmadpour; Muktar Beshir Ahmed; Mohammad Esmaeil Akbari; Tomi Akinyemiju; Ziyad Al-Aly; Assim M AlAbdulKader; Fares Alahdab; Tahiya Alam; Genet Melak Alamene; Birhan Tamene T Alemnew; Kefyalew Addis Alene; Cyrus Alinia; Vahid Alipour; Syed Mohamed Aljunid; Fatemeh Allah Bakeshei; Majid Abdulrahman Hamad Almadi; Amir Almasi-Hashiani; Ubai Alsharif; Shirina Alsowaidi; Nelson Alvis-Guzman; Erfan Amini; Saeed Amini; Yaw Ampem Amoako; Zohreh Anbari; Nahla Hamed Anber; Catalina Liliana Andrei; Mina Anjomshoa; Fereshteh Ansari; Ansariadi Ansariadi; Seth Christopher Yaw Appiah; Morteza Arab-Zozani; Jalal Arabloo; Zohreh Arefi; Olatunde Aremu; Habtamu Abera Areri; Al Artaman; Hamid Asayesh; Ephrem Tsegay Asfaw; Alebachew Fasil Ashagre; Reza Assadi; Bahar Ataeinia; Hagos Tasew Atalay; Zerihun Ataro; Suleman Atique; Marcel Ausloos; Leticia Avila-Burgos; Euripide F G A Avokpaho; Ashish Awasthi; Nefsu Awoke; Beatriz Paulina Ayala Quintanilla; Martin Amogre Ayanore; Henok Tadesse Ayele; Ebrahim Babaee; Umar Bacha; Alaa Badawi; Mojtaba Bagherzadeh; Eleni Bagli; Senthilkumar Balakrishnan; Abbas Balouchi; Till Winfried Bärnighausen; Robert J Battista; Masoud Behzadifar; Meysam Behzadifar; Bayu Begashaw Bekele; Yared Belete Belay; Yaschilal Muche Belayneh; Kathleen Kim Sachiko Berfield; Adugnaw Berhane; Eduardo Bernabe; Mircea Beuran; Nickhill Bhakta; Krittika Bhattacharyya; Belete Biadgo; Ali Bijani; Muhammad Shahdaat Bin Sayeed; Charles Birungi; Catherine Bisignano; Helen Bitew; Tone Bjørge; Archie Bleyer; Kassawmar Angaw Bogale; Hunduma Amensisa Bojia; Antonio M Borzì; Cristina Bosetti; Ibrahim R Bou-Orm; Hermann Brenner; Jerry D Brewer; Andrey Nikolaevich Briko; Nikolay Ivanovich Briko; Maria Teresa Bustamante-Teixeira; Zahid A Butt; Giulia Carreras; Juan J Carrero; Félix Carvalho; Clara Castro; Franz Castro; Ferrán Catalá-López; Ester Cerin; Yazan Chaiah; Wagaye Fentahun Chanie; Vijay Kumar Chattu; Pankaj Chaturvedi; Neelima Singh Chauhan; Mohammad Chehrazi; Peggy Pei-Chia Chiang; Tesfaye Yitna Chichiabellu; Onyema Greg Chido-Amajuoyi; Odgerel Chimed-Ochir; Jee-Young J Choi; Devasahayam J Christopher; Dinh-Toi Chu; Maria-Magdalena Constantin; Vera M Costa; Emanuele Crocetti; Christopher Stephen Crowe; Maria Paula Curado; Saad M A Dahlawi; Giovanni Damiani; Amira Hamed Darwish; Ahmad Daryani; José das Neves; Feleke Mekonnen Demeke; Asmamaw Bizuneh Demis; Birhanu Wondimeneh Demissie; Gebre Teklemariam Demoz; Edgar Denova-Gutiérrez; Afshin Derakhshani; Kalkidan Solomon Deribe; Rupak Desai; Beruk Berhanu Desalegn; Melaku Desta; Subhojit Dey; Samath Dhamminda Dharmaratne; Meghnath Dhimal; Daniel Diaz; Mesfin Tadese Tadese Dinberu; Shirin Djalalinia; David Teye Doku; Thomas M Drake; Manisha Dubey; Eleonora Dubljanin; Eyasu Ejeta Duken; Hedyeh Ebrahimi; Andem Effiong; Aziz Eftekhari; Iman El Sayed; Maysaa El Sayed Zaki; Shaimaa I El-Jaafary; Ziad El-Khatib; Demelash Abewa Elemineh; Hajer Elkout; Richard G Ellenbogen; Aisha Elsharkawy; Mohammad Hassan Emamian; Daniel Adane Endalew; Aman Yesuf Endries; Babak Eshrati; Ibtihal Fadhil; Vahid Fallah Omrani; Mahbobeh Faramarzi; Mahdieh Abbasalizad Farhangi; Andrea Farioli; Farshad Farzadfar; Netsanet Fentahun; Eduarda Fernandes; Garumma Tolu Feyissa; Irina Filip; Florian Fischer; James L Fisher; Lisa M Force; Masoud Foroutan; Marisa Freitas; Takeshi Fukumoto; Neal D Futran; Silvano Gallus; Fortune Gbetoho Gankpe; Reta Tsegaye Gayesa; Tsegaye Tewelde Gebrehiwot; Gebreamlak Gebremedhn Gebremeskel; Getnet Azeze Gedefaw; Belayneh K Gelaw; Birhanu Geta; Sefonias Getachew; Kebede Embaye Gezae; Mansour Ghafourifard; Alireza Ghajar; Ahmad Ghashghaee; Asadollah Gholamian; Paramjit Singh Gill; Themba T G Ginindza; Alem Girmay; Muluken Gizaw; Ricardo Santiago Gomez; Sameer Vali Gopalani; Giuseppe Gorini; Bárbara Niegia Garcia Goulart; Ayman Grada; Maximiliano Ribeiro Guerra; Andre Luiz Sena Guimaraes; Prakash C Gupta; Rahul Gupta; Kishor Hadkhale; Arvin Haj-Mirzaian; Arya Haj-Mirzaian; Randah R Hamadeh; Samer Hamidi; Lolemo Kelbiso Hanfore; Josep Maria Haro; Milad Hasankhani; Amir Hasanzadeh; Hamid Yimam Hassen; Roderick J Hay; Simon I Hay; Andualem Henok; Nathaniel J Henry; Claudiu Herteliu; Hagos D Hidru; Chi Linh Hoang; Michael K Hole; Praveen Hoogar; Nobuyuki Horita; H Dean Hosgood; Mostafa Hosseini; Mehdi Hosseinzadeh; Mihaela Hostiuc; Sorin Hostiuc; Mowafa Househ; Mohammedaman Mama Hussen; Bogdan Ileanu; Milena D Ilic; Kaire Innos; Seyed Sina Naghibi Irvani; Kufre Robert Iseh; Sheikh Mohammed Shariful Islam; Farhad Islami; Nader Jafari Balalami; Morteza Jafarinia; Leila Jahangiry; Mohammad Ali Jahani; Nader Jahanmehr; Mihajlo Jakovljevic; Spencer L James; Mehdi Javanbakht; Sudha Jayaraman; Sun Ha Jee; Ensiyeh Jenabi; Ravi Prakash Jha; Jost B Jonas; Jitendra Jonnagaddala; Tamas Joo; Suresh Banayya Jungari; Mikk Jürisson; Ali Kabir; Farin Kamangar; André Karch; Narges Karimi; Ansar Karimian; Amir Kasaeian; Gebremicheal Gebreslassie Kasahun; Belete Kassa; Tesfaye Dessale Kassa; Mesfin Wudu Kassaw; Anil Kaul; Peter Njenga Keiyoro; Abraham Getachew Kelbore; Amene Abebe Kerbo; Yousef Saleh Khader; Maryam Khalilarjmandi; Ejaz Ahmad Khan; Gulfaraz Khan; Young-Ho Khang; Khaled Khatab; Amir Khater; Maryam Khayamzadeh; Maryam Khazaee-Pool; Salman Khazaei; Abdullah T Khoja; Mohammad Hossein Khosravi; Jagdish Khubchandani; Neda Kianipour; Daniel Kim; Yun Jin Kim; Adnan Kisa; Sezer Kisa; Katarzyna Kissimova-Skarbek; Hamidreza Komaki; Ai Koyanagi; Kristopher J Krohn; Burcu Kucuk Bicer; Nuworza Kugbey; Vivek Kumar; Desmond Kuupiel; Carlo La Vecchia; Deepesh P Lad; Eyasu Alem Lake; Ayenew Molla Lakew; Dharmesh Kumar Lal; Faris Hasan Lami; Qing Lan; Savita Lasrado; Paolo Lauriola; Jeffrey V Lazarus; James Leigh; Cheru Tesema Leshargie; Yu Liao; Miteku Andualem Limenih; Stefan Listl; Alan D Lopez; Platon D Lopukhov; Raimundas Lunevicius; Mohammed Madadin; Sameh Magdeldin; Hassan Magdy Abd El Razek; Azeem Majeed; Afshin Maleki; Reza Malekzadeh; Ali Manafi; Navid Manafi; Wondimu Ayele Manamo; Morteza Mansourian; Mohammad Ali Mansournia; Lorenzo Giovanni Mantovani; Saman Maroufizadeh; Santi Martini S Martini; Tivani Phosa Mashamba-Thompson; Benjamin Ballard Massenburg; Motswadi Titus Maswabi; Manu Raj Mathur; Colm McAlinden; Martin McKee; Hailemariam Abiy Alemu Meheretu; Ravi Mehrotra; Varshil Mehta; Toni Meier; Yohannes A Melaku; Gebrekiros Gebremichael Meles; Hagazi Gebre Meles; Addisu Melese; Mulugeta Melku; Peter T N Memiah; Walter Mendoza; Ritesh G Menezes; Shahin Merat; Tuomo J Meretoja; Tomislav Mestrovic; Bartosz Miazgowski; Tomasz Miazgowski; Kebadnew Mulatu M Mihretie; Ted R Miller; Edward J Mills; Seyed Mostafa Mir; Hamed Mirzaei; Hamid Reza Mirzaei; Rashmi Mishra; Babak Moazen; Dara K Mohammad; Karzan Abdulmuhsin Mohammad; Yousef Mohammad; Aso Mohammad Darwesh; Abolfazl Mohammadbeigi; Hiwa Mohammadi; Moslem Mohammadi; Mahdi Mohammadian; Abdollah Mohammadian-Hafshejani; Milad Mohammadoo-Khorasani; Reza Mohammadpourhodki; Ammas Siraj Mohammed; Jemal Abdu Mohammed; Shafiu Mohammed; Farnam Mohebi; Ali H Mokdad; Lorenzo Monasta; Yoshan Moodley; Mahmood Moosazadeh; Maryam Moossavi; Ghobad Moradi; Mohammad Moradi-Joo; Maziar Moradi-Lakeh; Farhad Moradpour; Lidia Morawska; Joana Morgado-da-Costa; Naho Morisaki; Shane Douglas Morrison; Abbas Mosapour; Seyyed Meysam Mousavi; Achenef Asmamaw Muche; Oumer Sada S Muhammed; Jonah Musa; Ashraf F Nabhan; Mehdi Naderi; Ahamarshan Jayaraman Nagarajan; Gabriele Nagel; Azin Nahvijou; Gurudatta Naik; Farid Najafi; Luigi Naldi; Hae Sung Nam; Naser Nasiri; Javad Nazari; Ionut Negoi; Subas Neupane; Polly A Newcomb; Haruna Asura Nggada; Josephine W Ngunjiri; Cuong Tat Nguyen; Leila Nikniaz; Dina Nur Anggraini Ningrum; Yirga Legesse Nirayo; Molly R Nixon; Chukwudi A Nnaji; Marzieh Nojomi; Shirin Nosratnejad; Malihe Nourollahpour Shiadeh; Mohammed Suleiman Obsa; Richard Ofori-Asenso; Felix Akpojene Ogbo; In-Hwan Oh; Andrew T Olagunju; Tinuke O Olagunju; Mojisola Morenike Oluwasanu; Abidemi E Omonisi; Obinna E Onwujekwe; Anu Mary Oommen; Eyal Oren; Doris D V Ortega-Altamirano; Erika Ota; Stanislav S Otstavnov; Mayowa Ojo Owolabi; Mahesh P A; Jagadish Rao Padubidri; Smita Pakhale; Amir H Pakpour; Adrian Pana; Eun-Kee Park; Hadi Parsian; Tahereh Pashaei; Shanti Patel; Snehal T Patil; Alyssa Pennini; David M Pereira; Cristiano Piccinelli; Julian David Pillay; Majid Pirestani; Farhad Pishgar; Maarten J Postma; Hadi Pourjafar; Farshad Pourmalek; Akram Pourshams; Swayam Prakash; Narayan Prasad; Mostafa Qorbani; Mohammad Rabiee; Navid Rabiee; Amir Radfar; Alireza Rafiei; Fakher Rahim; Mahdi Rahimi; Muhammad Aziz Rahman; Fatemeh Rajati; Saleem M Rana; Samira Raoofi; Goura Kishor Rath; David Laith Rawaf; Salman Rawaf; Robert C Reiner; Andre M N Renzaho; Nima Rezaei; Aziz Rezapour; Ana Isabel Ribeiro; Daniela Ribeiro; Luca Ronfani; Elias Merdassa Roro; Gholamreza Roshandel; Ali Rostami; Ragy Safwat Saad; Parisa Sabbagh; Siamak Sabour; Basema Saddik; Saeid Safiri; Amirhossein Sahebkar; Mohammad Reza Salahshoor; Farkhonde Salehi; Hosni Salem; Marwa Rashad Salem; Hamideh Salimzadeh; Joshua A Salomon; Abdallah M Samy; Juan Sanabria; Milena M Santric Milicevic; Benn Sartorius; Arash Sarveazad; Brijesh Sathian; Maheswar Satpathy; Miloje Savic; Monika Sawhney; Mehdi Sayyah; Ione J C Schneider; Ben Schöttker; Mario Sekerija; Sadaf G Sepanlou; Masood Sepehrimanesh; Seyedmojtaba Seyedmousavi; Faramarz Shaahmadi; Hosein Shabaninejad; Mohammad Shahbaz; Masood Ali Shaikh; Amir Shamshirian; Morteza Shamsizadeh; Heidar Sharafi; Zeinab Sharafi; Mehdi Sharif; Ali Sharifi; Hamid Sharifi; Rajesh Sharma; Aziz Sheikh; Reza Shirkoohi; Sharvari Rahul Shukla; Si Si; Soraya Siabani; Diego Augusto Santos Silva; Dayane Gabriele Alves Silveira; Ambrish Singh; Jasvinder A Singh; Solomon Sisay; Freddy Sitas; Eugène Sobngwi; Moslem Soofi; Joan B Soriano; Vasiliki Stathopoulou; Mu'awiyyah Babale Sufiyan; Rafael Tabarés-Seisdedos; Takahiro Tabuchi; Ken Takahashi; Omid Reza Tamtaji; Mohammed Rasoul Tarawneh; Segen Gebremeskel Tassew; Parvaneh Taymoori; Arash Tehrani-Banihashemi; Mohamad-Hani Temsah; Omar Temsah; Berhe Etsay Tesfay; Fisaha Haile Tesfay; Manaye Yihune Teshale; Gizachew Assefa Tessema; Subash Thapa; Kenean Getaneh Tlaye; Roman Topor-Madry; Marcos Roberto Tovani-Palone; Eugenio Traini; Bach Xuan Tran; Khanh Bao Tran; Afewerki Gebremeskel Tsadik; Irfan Ullah; Olalekan A Uthman; Marco Vacante; Maryam Vaezi; Patricia Varona Pérez; Yousef Veisani; Simone Vidale; Francesco S Violante; Vasily Vlassov; Stein Emil Vollset; Theo Vos; Kia Vosoughi; Giang Thu Vu; Isidora S Vujcic; Henry Wabinga; Tesfahun Mulatu Wachamo; Fasil Shiferaw Wagnew; Yasir Waheed; Fitsum Weldegebreal; Girmay Teklay Weldesamuel; Tissa Wijeratne; Dawit Zewdu Wondafrash; Tewodros Eshete Wonde; Adam Belay Wondmieneh; Hailemariam Mekonnen Workie; Rajaram Yadav; Abbas Yadegar; Ali Yadollahpour; Mehdi Yaseri; Vahid Yazdi-Feyzabadi; Alex Yeshaneh; Mohammed Ahmed Yimam; Ebrahim M Yimer; Engida Yisma; Naohiro Yonemoto; Mustafa Z Younis; Bahman Yousefi; Mahmoud Yousefifard; Chuanhua Yu; Erfan Zabeh; Vesna Zadnik; Telma Zahirian Moghadam; Zoubida Zaidi; Mohammad Zamani; Hamed Zandian; Alireza Zangeneh; Leila Zaki; Kazem Zendehdel; Zerihun Menlkalew Zenebe; Taye Abuhay Zewale; Arash Ziapour; Sanjay Zodpey; Christopher J L Murray
Journal:  JAMA Oncol       Date:  2019-12-01       Impact factor: 31.777

10.  Informing the delivery of cancer survivorship care in rural primary care practice.

Authors:  J R Klemp; C J Knight; B Lowry; T Long; C Bush; K Alsman; H Krebill; D Peereboom; L Overholser; K A Greiner
Journal:  J Cancer Surviv       Date:  2022-02-02       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.